[Lipidemic alterations in a child with acute lymphoblastic leukemia in treatment with L-aspariginase]

Minerva Pediatr. 1994 Apr;46(4):161-4.
[Article in Italian]

Abstract

The case of a child treated for Acute Lymphoblastic Leukemia (LLA) with high-dose L-asparaginase, (HD L-ase) presented alteration who of lipidemic values (rise of total cholesterol and triglyceride values) without toxicity is described. This finding has previously been reported in only a few patients. Parameters normalized with dietetic regimen. The authors underline the importance of the control, in patient during HD L-ase treatment of lipidic values too, especially when parents also have similar alterations.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Asparaginase / administration & dosage*
  • Asparaginase / therapeutic use*
  • Child
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Hyperlipidemias / complications*
  • Hyperlipidemias / enzymology
  • Lipid Metabolism*
  • Maternal Welfare
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*

Substances

  • Asparaginase